TRANSMEDICS GROUP INC (TMDX) Stock Fundamental Analysis
NASDAQ:TMDX - Nasdaq - US89377M1099 - Common Stock - Currency: USD
TMDX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of TMDX get a neutral evaluation. Nothing too spectacular is happening here. TMDX is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make TMDX a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
TMDX had positive earnings in the past year.
TMDX had a positive operating cash flow in the past year.
In the past 5 years TMDX reported 4 times negative net income.
TMDX had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
TMDX's Return On Assets of 8.05% is amongst the best of the industry. TMDX outperforms 89.84% of its industry peers.
TMDX has a better Return On Equity (22.53%) than 94.65% of its industry peers.
The Return On Invested Capital of TMDX (7.25%) is better than 83.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.05% | ||
| ROE | 22.53% | ||
| ROIC | 7.25% |
ROA(3y)-4.07%
ROA(5y)-12.78%
ROE(3y)-7.35%
ROE(5y)-22.97%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 13.49%, TMDX belongs to the best of the industry, outperforming 90.37% of the companies in the same industry.
TMDX's Operating Margin of 14.41% is amongst the best of the industry. TMDX outperforms 82.89% of its industry peers.
Looking at the Gross Margin, with a value of 59.79%, TMDX is in line with its industry, outperforming 59.36% of the companies in the same industry.
TMDX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.41% | ||
| PM (TTM) | 13.49% | ||
| GM | 59.79% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.32%
GM growth 5Y0.21%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TMDX is destroying value.
TMDX has more shares outstanding than it did 1 year ago.
TMDX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for TMDX has been reduced compared to a year ago.
2.2 Solvency
TMDX has an Altman-Z score of 5.37. This indicates that TMDX is financially healthy and has little risk of bankruptcy at the moment.
TMDX has a better Altman-Z score (5.37) than 79.14% of its industry peers.
The Debt to FCF ratio of TMDX is 29.44, which is on the high side as it means it would take TMDX, 29.44 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 29.44, TMDX is doing good in the industry, outperforming 69.52% of the companies in the same industry.
A Debt/Equity ratio of 1.61 is on the high side and indicates that TMDX has dependencies on debt financing.
TMDX has a Debt to Equity ratio of 1.61. This is amonst the worse of the industry: TMDX underperforms 85.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.61 | ||
| Debt/FCF | 29.44 | ||
| Altman-Z | 5.37 |
ROIC/WACC0.9
WACC8.06%
2.3 Liquidity
A Current Ratio of 9.86 indicates that TMDX has no problem at all paying its short term obligations.
The Current ratio of TMDX (9.86) is better than 91.44% of its industry peers.
TMDX has a Quick Ratio of 9.10. This indicates that TMDX is financially healthy and has no problem in meeting its short term obligations.
TMDX has a Quick ratio of 9.10. This is amongst the best in the industry. TMDX outperforms 91.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.86 | ||
| Quick Ratio | 9.1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 4725.00% over the past year.
The Revenue has grown by 48.09% in the past year. This is a very strong growth!
The Revenue has been growing by 79.64% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)4725%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%162.86%
Revenue 1Y (TTM)48.09%
Revenue growth 3Y144.36%
Revenue growth 5Y79.64%
Sales Q2Q%37.68%
3.2 Future
The Earnings Per Share is expected to grow by 49.75% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 21.08% on average over the next years. This is a very strong growth
EPS Next Y82.44%
EPS Next 2Y59.67%
EPS Next 3Y47.23%
EPS Next 5Y49.75%
Revenue Next Year35.41%
Revenue Next 2Y27.91%
Revenue Next 3Y24.46%
Revenue Next 5Y21.08%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
TMDX is valuated quite expensively with a Price/Earnings ratio of 61.55.
Based on the Price/Earnings ratio, TMDX is valued a bit cheaper than 65.24% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.99, TMDX is valued quite expensively.
Based on the Price/Forward Earnings ratio of 46.14, the valuation of TMDX can be described as expensive.
Based on the Price/Forward Earnings ratio, TMDX is valued a bit cheaper than the industry average as 67.91% of the companies are valued more expensively.
TMDX is valuated rather expensively when we compare the Price/Forward Earnings ratio to 36.36, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 61.55 | ||
| Fwd PE | 46.14 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, TMDX is valued a bit cheaper than 65.78% of the companies in the same industry.
TMDX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. TMDX is cheaper than 68.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 231.62 | ||
| EV/EBITDA | 43.51 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as TMDX's earnings are expected to grow with 47.23% in the coming years.
PEG (NY)0.75
PEG (5Y)N/A
EPS Next 2Y59.67%
EPS Next 3Y47.23%
5. Dividend
5.1 Amount
No dividends for TMDX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
118.8
-6.94 (-5.52%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners121.41%
Inst Owner Change-0.13%
Ins Owners2.98%
Ins Owner Change18.64%
Market Cap4.02B
Analysts81.25
Price Target154.02 (29.65%)
Short Float %24.37%
Short Ratio9.15
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)133.71%
Min EPS beat(2)100.04%
Max EPS beat(2)167.38%
EPS beat(4)3
Avg EPS beat(4)55.99%
Min EPS beat(4)-59.86%
Max EPS beat(4)167.38%
EPS beat(8)6
Avg EPS beat(8)145.25%
EPS beat(12)10
Avg EPS beat(12)114.95%
EPS beat(16)11
Avg EPS beat(16)83.13%
Revenue beat(2)2
Avg Revenue beat(2)9.07%
Min Revenue beat(2)4.34%
Max Revenue beat(2)13.8%
Revenue beat(4)3
Avg Revenue beat(4)4.75%
Min Revenue beat(4)-7.28%
Max Revenue beat(4)13.8%
Revenue beat(8)7
Avg Revenue beat(8)11.77%
Revenue beat(12)11
Avg Revenue beat(12)15.17%
Revenue beat(16)14
Avg Revenue beat(16)17.24%
PT rev (1m)7.82%
PT rev (3m)29.62%
EPS NQ rev (1m)1.37%
EPS NQ rev (3m)24.75%
EPS NY rev (1m)0%
EPS NY rev (3m)23.31%
Revenue NQ rev (1m)0.77%
Revenue NQ rev (3m)11.22%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)7.37%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 61.55 | ||
| Fwd PE | 46.14 | ||
| P/S | 7.56 | ||
| P/FCF | 231.62 | ||
| P/OCF | 34.86 | ||
| P/B | 12.63 | ||
| P/tB | 13.2 | ||
| EV/EBITDA | 43.51 |
EPS(TTM)1.93
EY1.62%
EPS(NY)2.57
Fwd EY2.17%
FCF(TTM)0.51
FCFY0.43%
OCF(TTM)3.41
OCFY2.87%
SpS15.7
BVpS9.4
TBVpS9
PEG (NY)0.75
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.05% | ||
| ROE | 22.53% | ||
| ROCE | 9.18% | ||
| ROIC | 7.25% | ||
| ROICexc | 13.96% | ||
| ROICexgc | 14.41% | ||
| OM | 14.41% | ||
| PM (TTM) | 13.49% | ||
| GM | 59.79% | ||
| FCFM | 3.27% |
ROA(3y)-4.07%
ROA(5y)-12.78%
ROE(3y)-7.35%
ROE(5y)-22.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.32%
GM growth 5Y0.21%
F-Score7
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.61 | ||
| Debt/FCF | 29.44 | ||
| Debt/EBITDA | 5.09 | ||
| Cap/Depr | 412.74% | ||
| Cap/Sales | 18.43% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 114.93% | ||
| Profit Quality | 24.21% | ||
| Current Ratio | 9.86 | ||
| Quick Ratio | 9.1 | ||
| Altman-Z | 5.37 |
F-Score7
WACC8.06%
ROIC/WACC0.9
Cap/Depr(3y)951.97%
Cap/Depr(5y)615.69%
Cap/Sales(3y)34.99%
Cap/Sales(5y)23.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4725%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%162.86%
EPS Next Y82.44%
EPS Next 2Y59.67%
EPS Next 3Y47.23%
EPS Next 5Y49.75%
Revenue 1Y (TTM)48.09%
Revenue growth 3Y144.36%
Revenue growth 5Y79.64%
Sales Q2Q%37.68%
Revenue Next Year35.41%
Revenue Next 2Y27.91%
Revenue Next 3Y24.46%
Revenue Next 5Y21.08%
EBIT growth 1Y6324.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year292.7%
EBIT Next 3Y89.1%
EBIT Next 5Y66.53%
FCF growth 1Y142.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y451.66%
OCF growth 3YN/A
OCF growth 5YN/A